A Phase III Study of YM177 (Postoperative Pain) -- An Etodolac- and Placebo-controlled, Multicenter, Double-blind, Group Comparison Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients.
Phase of Trial: Phase III
Latest Information Update: 19 Nov 2014
At a glance
- Drugs Celecoxib (Primary) ; Etodolac
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 05 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2010 New trial record